AVITA Medical Inc

Research AVITA Medical Inc (RCEL) on Bullrun: market cap USD 130.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRCEL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 130.80M
• Financial periodFY2025
• RevenueUSD 71.61M
• Revenue growth11.5%
• Net income-USD 48.59M
• Free cash flow-USD 32.20M
• Gross margin82.1%

Valuation Snapshot

latest market cap is USD 130.80M.

About AVITA Medical Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2;

Frequently asked questions

What is AVITA Medical Inc's market cap?

AVITA Medical Inc's market capitalization is USD 130.80M.

What does AVITA Medical Inc do?

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.